Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 935.50 GBp
Change Today -4.50 / -0.48%
Volume 6.0K
CSRT On Other Exchanges
Symbol
Exchange
OTC US
London
OTC US
London
London
As of 11:35 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

consort medical plc (CSRT) Snapshot

Open
946.00 GBp
Previous Close
940.00 GBp
Day High
946.00 GBp
Day Low
930.00 GBp
52 Week High
04/23/15 - 951.50 GBp
52 Week Low
10/21/14 - 650.00 GBp
Market Cap
459.1M
Average Volume 10 Days
111.2K
EPS TTM
0.44 GBp
Shares Outstanding
49.1M
EX-Date
01/15/15
P/E TM
21.3x
Dividend
20.12 GBp
Dividend Yield
2.15%
Current Stock Chart for CONSORT MEDICAL PLC (CSRT)

Related News

No related news articles were found.

consort medical plc (CSRT) Related Businessweek News

No Related Businessweek News Found

consort medical plc (CSRT) Details

Consort Medical plc designs, develops, manufactures, and sells specialty medical drug delivery devices and services to the pharmaceutical industry in Europe, the United States, and internationally. It offers metered dose inhaler valves, dry powder inhalers, integrated dose counters, actuators, disposable auto injectors, needle-free injectors, nasal drug delivery devices, nicotine inhalation devices, point of care diagnostics devices, and medical check valves, which are used to treat asthma and chronic obstructive pulmonary diseases. The company also manufactures anodized parts and pressings; and offers auto-injector platforms, syringe systems, video laryngoscopes, and narina nasal products, as well as provides commercial services. Consort Medical plc was incorporated in 1946 and is based in Hemel Hempstead, the United Kingdom.

657 Employees
Last Reported Date: 07/30/14
Founded in 1946

consort medical plc (CSRT) Top Compensated Officers

Chief Executive Officer, Director, Member of ...
Total Annual Compensation: 834.0K GBP
Chief Financial Officer, Group Finance Direct...
Total Annual Compensation: 465.0K GBP
Compensation as of Fiscal Year 2014.

consort medical plc (CSRT) Key Developments

Consort Medical plc. Presents at 40th Annual Deutsche Bank Health Care Conference, May-06-2015 10:40 AM

Consort Medical plc. Presents at 40th Annual Deutsche Bank Health Care Conference, May-06-2015 10:40 AM. Venue: The InterContinental Hotel, 510 Atlantic Ave, Boston, MA 02210, United States. Speakers: Richard John Cotton, Chief Financial Officer, Group Finance Director, Director and Member of Executive Committee.

Consort Medical plc Appoints Maria Charlotta Ginman-Jones as a Non-Executive Director

The Board of Consort Medical plc announced the appointment of Ms. Maria Charlotta Ginman-Jones (known as Ms. Charlotta Ginman) as a Non-executive Director with effect from Wednesday February 11, 2015. Ms. Ginman will join the Nomination and Audit Committees. Ms. Ginman is a Non-executive Director of Kromek Group plc and is also a Non-executive Director of Pacific Assets Trust plc and Polar Capital Technology Trust plc.

Consort Medical plc announces Integrated Dose Counter Supply Agreement

Consort Medical plc announced the conclusion of a significant new commercial supply agreement for its proprietary integrated dose counter (IDC) system. The multi-year supply agreement covers supply of both the IDC actuator and the pressurised metered dose inhaler (pMDI) valve. This IDC programme represents the first commercial oral variant of the device, which is already approved and marketed for a nasally delivered product. Dose-counting devices fulfil an important patient and compliance need to let patients know if their device contains sufficient drug and to indicate when they need to seek a further prescription. It provides patients with a reliable, easy to read indication of how many doses are left inside the canister in line with FDA guidance.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CSRT:LN 935.50 GBp -4.50

CSRT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Carclo PLC 153.75 GBp -1.25
Gerresheimer AG €54.05 EUR +0.032
Rexam PLC 567.00 GBp +2.00
West Pharmaceutical Services Inc $55.13 USD +0.45
View Industry Companies
 

Industry Analysis

CSRT

Industry Average

Valuation CSRT Industry Range
Price/Earnings 19.9x
Price/Sales 2.6x
Price/Book 2.3x
Price/Cash Flow 22.5x
TEV/Sales 4.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CONSORT MEDICAL PLC, please visit www.consortmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.